Rigaku Corporation, a global leader in X-ray analytical equipment and a member of the Rigaku Holdings Group, has officially opened the Rigaku Bioscience Laboratory in Cambridge, Massachusetts. Rigaku Corporation has begun operating its MoleQlyze technology at the newly opened Rigaku…
Exai Bio, a next-generation company specializing in oncRNA and generative AI-based liquid biopsy technologies, has announced the publication of a peer-reviewed paper in Nature Communications. The study, titled “Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of…
Greenspace Health, a leading provider of Measurement-Based Care (MBC) technology for behavioral health services, has been named to the 2024 Deloitte Technology Fast 500™. This prestigious ranking highlights the 500 fastest-growing companies in North America across technology, media, telecommunications, life…
Aptar Digital Health, a global leader in digital health solutions, has announced a partnership with the Quality of Life (QoL) technologies lab at the University of Geneva, Switzerland, to enhance migraine research. The collaboration aims to improve the understanding of…
Nym, a leader in autonomous medical coding, has been recognized in The Healthcare Technology Report’s list of Top 100 Healthcare Technology Companies for 2024. This accolade highlights Nym’s significant contribution to automating and streamlining revenue cycle management for healthcare providers,…
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration and licensing agreement with Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK). The partnership will aim to develop Takeda’s proprietary induced pluripotent…
STIMIT AG announced today that it is enrolling patients in its FDA Investigational Device Exemption (IDE) clinical trial, the “STIMIT ACTIVATOR 1 PIVOTAL STUDY,” in collaboration with leading clinical centers worldwide. The trial will assess the safety and effectiveness of…
Signature Healthcare has partnered with NRC Health to strengthen its network with human-centered healthcare solutions and advanced, data-driven insights that foster a deeper understanding of patients, employees, and communities. This collaboration supports Signature Healthcare’s mission to become the leading community-based…
Laekna, Inc. (2105.HK), a global biotech company focused on developing novel therapies for metabolic and cancer diseases, is excited to announce a clinical collaboration with Eli Lilly and Company (Lilly), a leader in cardiometabolic health, including diabetes and obesity. The…
DT Research, a leading provider of purpose-built computing solutions for vertical markets, and swyMed™, a top provider of telemedicine and connectivity solutions, announced that Washington County Regional Medical Center (WCRMC) is using their technologies for its EMS telemedicine services, supported…
After nearly 30 years as a leader in lab quality management, MediaLab has announced its rebrand to Vastian. This change reflects the company’s growth and expansion to address the broader quality and accreditation needs of hospitals and health systems. Vastian…
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has announced the launch of its ALISCA™-Breast1 Phase II trial (PUMA-ALI-1201; NCT06369285). The study will evaluate alisertib, in combination with endocrine therapy, for the treatment of hormone receptor-positive (HR+), HER2-negative recurrent or…